{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:58:56Z","timestamp":1788238736297,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["50-50110-96-518"],"award-info":[{"award-number":["50-50110-96-518"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eprac.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T08:07:41Z","timestamp":1705824461000},"page":"348-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discriminatory Value of Steroid Hormones on Polycystic Ovary Syndrome and Clustering of Hyperandrogenism and Metabolic Factors"],"prefix":"10.1016","volume":"30","author":[{"given":"Zheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-6263","authenticated-orcid":false,"given":"Martijn","family":"Van Faassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6629-318X","authenticated-orcid":false,"given":"Henk","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid E.P.","family":"Cantineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Van Oers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Keevil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-7142","authenticated-orcid":false,"given":"Annemieke","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2024.01.007_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eprac.2024.01.007_bib2","first-page":"261","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.eprac.2024.01.007_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2011.11.026","article-title":"Do women with PCOS have a unique predisposition to obesity?","volume":"97","author":"Hoeger","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eprac.2024.01.007_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-21-0703","article-title":"Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study","volume":"186","author":"Loh","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2265.1992.tb02262.x","article-title":"Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance","volume":"36","author":"Robinson","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590400002300","article-title":"Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome","volume":"19","author":"Hirschberg","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0032-1328878","article-title":"Obesity and PCOS: implications for diagnosis and treatment","volume":"30","author":"Legro","year":"2012","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.eprac.2024.01.007_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"10.1016\/j.eprac.2024.01.007_bib9","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2024.01.007_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eprac.2024.01.007_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1210\/jc.2014-2523","article-title":"Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome","volume":"100","author":"M\u00fcnzker","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.01.007_bib12","article-title":"Steroid mass spectrometry for the diagnosis of PCOS","volume":"7","author":"Keevil","year":"2019","journal-title":"Med Sci"},{"key":"10.1016\/j.eprac.2024.01.007_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O'Reilly","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2019-0959","article-title":"Development of a total serum testosterone, androstenedione, 17-hydroxyprogesterone, 11\u03b2-hydroxyandrostenedione and 11-ketotestosterone LC-MS\/MS assay and its application to evaluate pre-analytical sample stability","volume":"58","author":"Hawley","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2024.01.007_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when?","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.eprac.2024.01.007_bib16","article-title":"Principal component analysis: a review and recent developments","volume":"374","author":"Jolliffe","year":"2016","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.eprac.2024.01.007_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.metabol.2014.05.004","article-title":"Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis","volume":"63","author":"Stuckey","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.eprac.2024.01.007_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12020-014-0340-9","article-title":"Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients","volume":"48","author":"Albu","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.007_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190662","article-title":"Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: a randomized controlled trial","volume":"13","author":"van Dammen","year":"2018","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.eprac.2024.01.007_bib20","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa1505297","article-title":"Randomized trial of a lifestyle program in obese infertile women","volume":"374","author":"Mutsaerts","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eprac.2024.01.007_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6874-10-22","article-title":"The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial","volume":"10","author":"Mutsaerts","year":"2010","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.eprac.2024.01.007_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eprac.2024.01.007_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinbiochem.2019.03.013","article-title":"Development and validation of a LC-MS\/MS method for the establishment of reference intervals and biological variation for five plasma steroid hormones","volume":"68","author":"van der Veen","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.eprac.2024.01.007_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2024.01.007_bib25","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A\u00a0critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2024.01.007_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.eprac.2024.01.007_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1536867X0900900102","article-title":"Accommodating covariates in ROC analysis","volume":"9","author":"Janes","year":"2009","journal-title":"STATA J"},{"key":"10.1016\/j.eprac.2024.01.007_bib29","article-title":"Supplementary material for peer review","author":"Wang","year":"2023","journal-title":"Figshare"},{"key":"10.1016\/j.eprac.2024.01.007_bib30","article-title":"11-Oxyandrogens in adolescents with polycystic ovary syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.eprac.2024.01.007_bib31","article-title":"Association of classic and 11-oxygenated androgens with polycystic ovaries and menstrual cycle prolongation in infertile women with PCOS. Clinica chimica acta","volume":"547","author":"Ma Data Analysis","year":"2023","journal-title":"Internat J Clin Chem"},{"key":"10.1016\/j.eprac.2024.01.007_bib32","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.01.007_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","article-title":"Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population","volume":"12","author":"Mumusoglu","year":"2020","journal-title":"Current Opinion Endocrine Metab Res"},{"key":"10.1016\/j.eprac.2024.01.007_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2024.01.007_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib37","first-page":"83","article-title":"Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women","volume":"10","author":"Alexander","year":"2009","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.eprac.2024.01.007_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1056-8727(01)00191-X","article-title":"The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states","volume":"16","author":"Rashid","year":"2002","journal-title":"J\u00a0Diabet Complicat"},{"key":"10.1016\/j.eprac.2024.01.007_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eprac.2024.01.007_bib40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: a northern Finland birth cohort 1966 study","volume":"104","author":"Ollila","year":"2018","journal-title":"J\u00a0Clini Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.01.007_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary\u00a0artery\u00a0disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib42","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/deg218","article-title":"Cardiovascular risk factors in young Czech females with polycystic ovary syndrome","volume":"18","author":"Vrb\u00edkov\u00e1","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eprac.2024.01.007_bib43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.dsx.2018.03.014","article-title":"Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"12","author":"Fazleen","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.eprac.2024.01.007_bib44","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2007-0190","article-title":"Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib46","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","article-title":"Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism","volume":"95","author":"Dewailly","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.007_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-07-0203","article-title":"Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome","volume":"157","author":"Kajaia","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2024.01.007_bib48","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/jc.2002-020557","article-title":"The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance","volume":"88","author":"Jayagopal","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metabol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T04:00:34Z","timestamp":1729051234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1530891X24000417"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discriminatory Value of Steroid Hormones on Polycystic Ovary Syndrome and Clustering of Hyperandrogenism and Metabolic Factors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}